UPDATE : Monday, June 18, 2018
상단여백
Samsung BioLogics shares recover despite window dressing controversy by Nam Doo-hyun 2018-05-10 11:08
Bio & Medical Korea 2018 kicks off by Lee Han-soo 2018-05-09 11:55
Va-Q-Tec to up investment in Korean biopharmaceuticals by Nam Doo-hyun 2018-05-09 11:54
Pharma, biotech shares tank amid Samsung BioLogics debacle by Nam Doo-hyun 2018-05-08 11:20
Celltrion launches third biosimilar in EU by Lee Han-soo 2018-05-04 17:21
라인
Samsung BioLogics denies accounting irregularities by Lee Han-soo 2018-05-02 17:12
VC investment in biomedicine rises 200% y-o-y in Q1 by Nam Doo-hyun 2018-04-30 14:14
Chong Kun Dang wins US patent for anemia biosimilar by Lee Han-soo 2018-04-27 15:39
Hugel posts ₩45.8 billion in Q1 sales by Lee Han-soo 2018-04-26 12:51
Samsung BioLogics posts ₩131 billion in Q1 sales by Lee Han-soo 2018-04-25 17:47
라인
Pharma shares on the rise since early this year by Nam Doo-hyun 2018-04-25 13:56
NIBEC wins anti-cancer peptide patent in the US by Lee Han-soo 2018-04-23 15:15
Kolon unveils trial results for Invossa at cartilage repair conference by Lee Han-soo 2018-04-20 15:57
Blockbuster Remicade losing out to Korean biosimilars in US by So Jae-hyeon 2018-04-19 15:39
Hanmi gets FDA nod for nonalcoholic steatohepatitis treatment trials by Lee Han-soo 2018-04-19 15:29
라인
Biotech stocks could be overpriced: analysts by Nam Doo-hyun 2018-04-19 13:34
Pharmbio to market Shionogi’s dyspareunia treatment by Lee Han-soo 2018-04-18 14:10
ViroMed confirms VM202’s pain control in animal test by Nam Doo-hyun 2018-04-18 11:39
‘Genexine’s pipelines worth more than ₩3 trillion’ by Nam Doo-hyun 2018-04-16 15:48
Daewoong opens biotech research lab in Indonesia by So Jae-hyeon 2018-04-12 11:37
여백
여백
여백
Back to Top